SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-015291
Filing Date
2021-04-30
Accepted
2021-04-30 16:25:37
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10023585x2_defa14a.htm DEFA14A 40570
2 nc10023585x2_nc01.jpg GRAPHIC 745719
3 nc10023585x2_nc02.jpg GRAPHIC 608944
  Complete submission text file 0001140361-21-015291.txt   1907732
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36829 | Film No.: 21878500
SIC: 2834 Pharmaceutical Preparations